INO: Inovio Pharmaceuticals, Inc. Stock

by  •  • Comments Off on INO: Inovio Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 63.07
Enterprise Value ($M) -2.75
Book Value ($M) 68.50
Book Value / Share 1.87
Price / Book 0.92
NCAV ($M) 53.14
NCAV / Share 1.45
Price / NCAV 1.19

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -0.83
Return on Equity (ROE) -1.14

Liquidity (mrq)
Quick Ratio 2.77
Current Ratio 2.77

Balance Sheet (mrq) ($M)
Current Assets 97.83
Assets 113.20
Liabilities 44.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.22
Operating Income -112.40
Net Income -107.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -104.08
Cash from Investing 104.07
Cash from Financing 51.48

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A BlackRock, Inc. 6.30 21.48
02-10 13G Highbridge Capital Management Llc 9.20
01-30 13G/A Vanguard Group Inc 4.64 -91.53
12-23 13G Stonepine Capital Management, LLC 5.20
04-26 13G Deep Track Capital, LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 74,558 299,603 24.89
2025-04-16 113,844 365,629 31.14
2025-04-15 148,317 442,474 33.52
2025-04-14 339,918 755,902 44.97

(click for more detail)

Similar Companies
INKT – MiNK Therapeutics, Inc. INM – InMed Pharmaceuticals Inc.
INMB – INmune Bio, Inc. INTS – Intensity Therapeutics, Inc.
IPA – ImmunoPrecise Antibodies Ltd.


Financial data and stock pages provided by
Fintel.io